MarioRVelascoMD

PubMed

• 73 citations
  Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma
  Daniel J Olson, Zeynep Eroglu, Bruce Brockstein, Andrew Poklepovic, Madhuri Bajaj, Sunil Babu, Sigrun Hallmeyer, Mario R. Velasco, Jose Lutzky, Emily F. Higgs, Riyue B...> ;Journal of Clinical Oncology. 2021 May 4
• 2 citations
  A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxiciti...
  Siu-Fun Wong, Joseph M. Unger, James L. Wade, Lynne I. Wagner, Mario E. Lacouture, Keisha C. Humphries, Anna Moseley, Kathryn B. Arnold, Mario R. Velasco, Justin D. Fl...> ;Journal of Patient-Reported Outcomes. 2020 Jul 8
• 4 citations
  Personalized Management of Chemotherapy-Induced Peripheral Neuropathy Based on a Patient Reported Outcome: CALGB 40502 (Alliance)
  Manish R. Sharma, Shailly Mehrotra, Elizabeth Gray, Kehua Wu, William T. Barry, Clifford A. Hudis, Eric P. Winer, Alan P. Lyss, Deborah Toppmeyer, Alvaro Moreno-Aspiti...> ;Journal of Clinical Pharmacology. 2020 Apr 1
• 26 citations
  Phase II Trial of Cediranib in Combination With Cisplatin and Pemetrexed in Chemotherapy-Naïve Patients With Unresectable Malignant Pleural Mesothelioma (SWOG S0905).
  Anne S. Tsao, Jieling Miao, Ignacio I. Wistuba, Nicholas J. Vogelzang, John V. Heymach, Frank V. Fossella, Charles Lu, Mario R. Velasco, Brandy Box-Noriega, James Gilb...> ;Journal of Clinical Oncology. 2019 Aug 6
• 17 citations
  Cetuximab Combined With Induction Oxaliplatin and Capecitabine, Followed by Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer: SWOG 0713
  Cynthia G. Leichman, Shannon McDonough, Stephen R. Smalley, Kevin G. Billingsley, Heinz-Josef Lenz, Matthew A. Beldner, Aram F. Hezel, Mario R. Velasco, Katherine A. G...> ;Clinical Colorectal Cancer. 2017 Oct 24
• 175 citations
  Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocyt...
  Mikkael A. Sekeres, Megan Othus, Alan F. List, Olatoyosi Odenike, Richard Stone, Steven D. Gore, Mark R. Litzow, Rena Buckstein, Min Fang, Diane Roulston, Clara D. Blo...> ;Journal of Clinical Oncology. 2017 May 9
• 211 citations
  Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial.
  Andrew L. Himelstein, Jared C. Foster, James L. Khatcheressian, John D. Roberts, Drew K. Seisler, Paul J. Novotny, Rui Qin, Ronald S. Go, Stephen Grubbs, Tracey O'Conn...> ;JAMA. 2017 Jan 3
• 55 citations
  Vismodegib or cixutumumab in combination with standard chemotherapy for patients with extensive-stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research...
  Chandra P. Belani, Suzanne E. Dahlberg, Charles M. Rudin, Martin Fleisher, Helen X. Chen, Naoko Takebe, Mario R. Velasco, William Tester, Keren Sturtz, Christine L. Ha...> ;Cancer. 2016 Aug 1
• 21 citations
  Phase II trial of carboplatin, paclitaxel, cetuximab, and bevacizumab followed by cetuximab and bevacizumab in advanced nonsquamous non-small-cell lung cancer SWOG S0536
  Edward S. Kim, James J. Moon, Roy S. Herbst, Mary W. Redman, Shaker R. Dakhil, Mario R. Velasco, Fred R. Hirsch, Philip C. Mack, Karen Kelly, John V. Heymach, David R....> ;Journal of Thoracic Oncology. 2013 Dec 1
• A randomized, double-blinded, placebo-controlled trial of oral alpha lipoic acid to prevent platinum-induced polyneuropathy.
  Guo Y, Palmer JL, Forman A, Dakhil SR, Velasco MR, Weiss M, Gilman P, Mills GM, Noga SJ, Eng C, Overman MJ, Fisch M> ;J. Clin. Oncol.. 2011-05-20
• 19 citations
  Cetuximab for the Treatment of Advanced Bronchioloalveolar Carcinoma (BAC): An Eastern Cooperative Oncology Group Phase II Study (ECOG 1504)
  Suresh S. Ramalingam, Ju Whei Lee, Chandra P. Belani, Seena C. Aisner, Jill M. Kolesar, Craig Howe, Mario R. Velasco, Joan H. Schiller> ;Journal of Clinical Oncology. 2011 May 1
• Residual tumor status in clinical trials of advanced ovarian cancer: A systematic review.
  Beltrán M, Hernández X, Abal C, Velasco M, Rubio J, Colomer R> ;J. Clin. Oncol.. 2006-06-20
• Join now to see all